Volume 1, Issue 2, September 2015, Page: 27-32
Evaluation of Prevention Bundle Application for Ventilator-Associated Pneumonia in Intensive Care Units
Ilknur Esen Yildiz, Department of Clinical Microbiology and Infectious Diseases, Medicine Faculty of Ondokuz Mayis University, Samsun, Turkey
Hava Yilmaz, Department of Clinical Microbiology and Infectious Diseases, Medicine Faculty of Ondokuz Mayis University, Samsun, Turkey
Ahmet Dilek, Department of Anesthesiology and Reanimation, Ondokuz Mayis University School of Medicine, Samsun, Turkey
Saban Esen, Department of Clinical Microbiology and Infectious Diseases, Medicine Faculty of Ondokuz Mayis University, Samsun, Turkey
Mustafa Sunbul, Department of Clinical Microbiology and Infectious Diseases, Medicine Faculty of Ondokuz Mayis University, Samsun, Turkey
Hakan Leblebicioglu, Department of Clinical Microbiology and Infectious Diseases, Medicine Faculty of Ondokuz Mayis University, Samsun, Turkey
Received: Aug. 14, 2015;       Accepted: Aug. 28, 2015;       Published: Sep. 2, 2015
DOI: 10.11648/j.jfmhc.20150102.13      View  4580      Downloads  138
Abstract
Objective: The current study investigated the applicability of the VAP prevention bundle and its effect on rates of VAP. Methods: This study was performed in the intensive care units (ICU) of anesthesia (AICU) and the neurology (NICU) in the Medical Faculty of Ondokuz Mayis University from October 2011 to September 2012 (for one year). Mechanically ventilated patients in the ICU for 48 hours were included. The bundle components were patient’s head elevated to 30–45°, assessment of daily extubation status (weaning), peptic ulcer prophylaxis, deep vein thrombosis (DVT) prophylaxis, and oral care with chlorhexidine. The VAP rate and ventilator usage rates were calculated and compared in quarterly periods for one year. Results: In the study, 35 patients developed VAP. There was full compliance with the prevention bundle in 30.5% of cases. No VAP developed in 51 patients whose compliance with the prevention bundle was 100%. In patients (n=35) whose compliance with prevention bundle was more than 50%, VAP (n=6) developed in 19% of the patients. But, in patients (n=35) whose compliance with prevention bundle was less than 50%, VAP (n=29) developed in 82.8% of the patients. There was a significant relationship between compliance with the prevention bundle and development of VAP (P<0.05). Conclusion: VAP rates reduced by the end of the one-year. To reach a zero infection target, ensuring and maintaining full compliance with all components of the prevention bundle are essential.
Keywords
Ventilator-Associated Pneumonia, Prevention Bundle, Intensive Care Units, VAP Rate
To cite this article
Ilknur Esen Yildiz, Hava Yilmaz, Ahmet Dilek, Saban Esen, Mustafa Sunbul, Hakan Leblebicioglu, Evaluation of Prevention Bundle Application for Ventilator-Associated Pneumonia in Intensive Care Units, Journal of Family Medicine and Health Care. Vol. 1, No. 2, 2015, pp. 27-32. doi: 10.11648/j.jfmhc.20150102.13
Reference
[1]
Lawrence P, Fulbrook P. The ventilator care bundle and its impact on ventilator-associated pneumonia: a review of the evidence. Nurs Crit Care 2010; 16:222-234.
[2]
Berenholtz SM, Pham JC, Thompson DA, Needham DM, Lubomski LH, Hyzy RC, Welsh R, Cosgrove SE, Sexton JB, Colantuoni E, Watson SR, Goeschel CA, Pronovost PJ. Collaborative cohort study of an intervention to reduce ventilator-associated pneumonia in the intensive care unit. Infect Control Hosp Epidemiol 2011; 32:305-314.
[3]
5 million lives campaign. Getting started kit: Prevent ventilator-associated pneumonia how-to guide. Cambridge, MA: Institute for Healthcare Improvement 2010.
[4]
Berenholtz SM, Pronovost PJ, Lipsett PA, Hobson D, Earsing K, Farley JE, Milanovich S, Garrett-Mayer E, Winters BD, Rubin HR, Dorman T, Perl TM. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32:2014-2020.
[5]
Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Recommendations of CDC and the healthcare infection control practices advisory committee. Guidelines for preventing health-care-associated pneumonia 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53:1-36.
[6]
Yıldız IS, Esen S, Sunbul M, Yilmaz H, Ulger F, Leblebicioglu H. Yoğun Bakım Ünitelerinde Endotrakeal Aspirasyon İşleminin Standartlara Uyumunun İzlenmesi. EKMUD 2013 Bilimsel Platformu. 2013 Antalya. Poster No:037.
[7]
Beattie M, Shepherd A, Maher S, Grant J. Continual improvement in ventilator acquired pneumonia bundle compliance: A retrospective case matched review. Intensive Crit Care Nurs 2013; 28:255-262.
[8]
WHO/WPRO/SEARO. Practical guidelines for infection control in health care facilities. Geneva: SEARO Regional Publication 2004; No: 41.
[9]
Zingg W, Walder B, Pittet D. Prevention of catheter-related infection: toward zero risk? Curr Opin Infect Dis 2011; 24:377-384.
[10]
Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Morrel G, Pollock DA, Edwards JR National Healthcare Safety Network (NHSN) report, data summary for 2010, Device-associated module. Am J Infect Control 2011; 39:798-816.
[11]
National Hospital Infections Surveillance Network (UHESA) Report. Summary Data: 2012. Turkey, Ministry of Health (April 2013:17-18).
[12]
Leblebicioglu H, Rosenthal VD, Arikan OA, Ozgültekin A, Yalcin AN, Koksal I, Usluer G, Sardan YC, Ulusoy S. Turkish Branch of INICC. Device-associated hospital acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INCC). J Hosp Infect 2007; 65:251-257.
[13]
Üstün C, Hoşoğlu S, Geyik MF, Aluçlu MU. Device associated nosocomial infections in norological intensive care unit. Firat Medical Journal 2008; 3:179-182.
[14]
Kilinçalp S. Evaluation of prevention bundle application for ventilator associated pnuomonia in internal medicine intensive care unit (thesis). Ankara; Hacettepe University Medicine Faculty 2010.
[15]
Youngquist P, Carroll M, Farber M, Macy D, Madrid P, Ronning J, Susag A. Implementing a ventilator bundle in a community hospital. Jt Comm J Qual Patient Saf 2007; 33:219-225.
[16]
American Thoracic Society Infectious Diseases Society of America: Guidelines for the management of adults with Hospital-acquired, Ventilator-associated and Healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
[17]
Alp E. Nosocomial Pneumonia in Intensive Care Units (thesis) Kayseri: Erciyes University Medicine Faculty 2002.
[18]
Agarwal R, Gupta D, Ray P, Aggarwal AN, Jindal SK. Epidemiology, risk factors and outcome of nosocomial infections in a respiratory intensive care unit in North India. J Infect 2006;53:98-105.
[19]
Hugonnet S, Uckay I, Pittet D. Staffing level: a determinant of late-onset ventilator-associated pneumonia. Crit Care 2007; 11:R80.
[20]
Craven DE, Chroneou A. Nosocomial pneumonia. In Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone. 2010. 3717-3724 p.
[21]
Bonello RS, Fletcher CE, Becker WK, Clutter KL, Arjes SL, Cook JJ, Petzel RA. An intensive care unit quality improvement collaborative in nine department of veterans affairs hospitals: reducing ventilator-associated pneumonia and catheter-related bloodstream infection rates. Jt Comm J Qual Patient Saf 2008; 34:639-645.
[22]
Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator associated pneumonia. Jt Comm J Qual Patient Saf 2005; 31:243-248.
[23]
Hampton DC, Griffith D, Howard A Evidence-based clinical improvements for mechanically ventilated patients. Rehabilitation Nursing 2005; 30:160-165.
[24]
Leblebicioglu H, Yalcin AN, Rosenthal VD, Koksal I, Sirmatel F, Unal S, Turgut H, Ozdemir D, Ersoz G, Uzun C, Ulusoy S, Esen S, Ulger F, Dilek A, Yilmaz H, Turhan O, Gunay N, Gumus E, Dursun O, Yilmaz G, Kaya S, Ulusoy H, Cengiz M, Yilmaz L, Yildirim G, Topeli A, Sacar S, Sungurtekin H, Ugurcan D, Geyik MF,Sahin A, Erdogan S, Kaya A, Kuyucu N, Arda B, Bacakoglu F. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in 11 adult intensive care units from 10 cities of Turkey: findings of the International Nosocomial Infection Control Consortium (INICC). Infection 2012; 41:447-456.
[25]
Rello J, Lorente C, Bodí M, Diaz E, Ricart M, Kollef MH. Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia?: A survey based on the opinions of an international panel of intensivists. Chest 2002;122:656-661.
[26]
Kollef MH, Silver P, Murphy DM, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995; 108:1655-1662.
[27]
Rello J, Lode H, Cornaglia G, Masterton RA. European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Med 2010; 36:773-780.
[28]
Aybar M, Topeli A Epidemiology of Ventilator Associated Pneumonia in a Medical İntensive Care Unit. Intensive Care Journal 2001; 1:41-66.
[29]
Doğanay M. Nosocomial infections in surgery services. ANKEM Journal 2005; 19:154-156.
[30]
Yilmaz G, Çaylan R, Ulusoy H, Aydin K, Erciyes N, Köksal I. The Evaluation of ventilator associated pneumonia diagnosed in intensive care unit. Crit Care Med I 2004; 4:131-137.
Browse journals by subject